- Investigator
- Whitney W Woodmansee
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Pituitary Neoplasms , 14 publications
- Human Growth Hormone , 11 publications
- Adenoma , 9 publications
- Pituitary Gland , 8 publications
Research activity
Focus
Dr. Woodmansee has been involved in both basic science and clinical research and has numerous publications in the pituitary/thyroid field. Spending much of her career specializing in pituitary and thyroid disorders, she has also served as director of the Clinical Neuroendocrine Program at the Brigham and Women’s Hospital/ Harvard Medical School in Boston, MA and the medical director of the Neuroendocrine/Pituitary Program at the Mayo Clinic in Jacksonville, FL. Dr. Woodmansee has been a principal investigator in a number of clinical trials related to pituitary disorders and her current primary research interest is in the area of hypopituitarism. She specializes in treating patients with pituitary and thyroid disorders.
Active clinical trials
My publications
Filter publications
54 publications
2022
Evaluation of multinodular goiter and primary hyperparathyroidism leads to a diagnosis of AL amyloidosis.
Thyroid research
PubMed • Publisher's site2022
Prevalence and Characteristics of Hyperthyroidism Among Patients With Sarcoidosis in the United States.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
PubMed • Publisher's site2022
Quality of life after long-term biochemical control of acromegaly.
Pituitary
PubMed • Publisher's site2021
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study.
ERJ open research
PubMed • Publisher's site2019
Pituitary Disorders in Pregnancy.
Neurologic clinics
PubMed • Publisher's site